Detalles de la búsqueda
1.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608183
2.
Epigenetic challenges on the horizon of chimeric antigen receptor-T.
Cytotherapy
; 26(5): 411-412, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466261
3.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107338
4.
Primary extranodal non-Hodgkin's lymphoma of the vagina: a case report and a review of the literature.
Acta Haematol
; 128(1): 33-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22584110
5.
Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis.
Hematol Oncol
; 29(3): 139-43, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21922508
6.
Immune reactivity during COVID-19: Implications for treatment.
Immunol Lett
; 231: 28-34, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421440
7.
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
Biol Blood Marrow Transplant
; 16(7): 1018-24, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20172040
8.
Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.
Hematol Oncol
; 28(4): 202-8, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21136583
9.
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
Am J Hematol
; 85(9): 687-90, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20652967
10.
Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.
Hematol Oncol
; 27(1): 40-5, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19206083
11.
Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
Hematol Oncol
; 27(4): 198-202, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19475701
12.
FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
Am J Hematol
; 84(8): 532-5, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19562748
13.
Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.
Anticancer Res
; 30(9): 3845-9, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20944181
14.
More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection.
Leuk Lymphoma
; 55(8): 1955-7, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24152050
Resultados
1 -
14
de 14
1
Próxima >
>>